Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
NL0012768675
Thu, 01.07.2021
IGEA Pharma N.V.
IGEA TO LAUNCH THE ALL EQUITY OFFER TO BLUE SKY NATURAL RESOURCES LTD.
Hoofddorp, the Netherlands, 30 June 2021. IGEA Pharma N.V. (SIX: IGPH) todayannounced the launch of the all equity offer (the "Offer") to Blue Sky Natural Resources Ltd.
According to the Offer, Blue Sky Natural Resources Shareholders will be entitled to receive 9 New IGEA Phar [ … ]
Thu, 03.06.2021
IGEA Pharma N.V.
IGEA announces changes in its board and other corporate updates
Hoofddorp, the Netherlands, 3 June 2021. IGEA Pharma N.V. (SIX: IGPH) today announced the resignation of Mrs. Rosanna Squitti and Mr. Giovanni Ferrario from its board of directors. Mr. Ferrario resigned for personal reasons and Mrs. Squitti left the corporate body for continuing to se [ … ]
Mon, 31.05.2021
IGEA Pharma N.V.
IGEA disclosed its Annual Report 2020
Hoofddorp, the Netherlands, 31 May 2021. IGEA Pharma N.V. (SIX: IGPH) today announced the disclosure if its Annual Report 2020.
Overview 2020
The group generated marginal revenue of TUSD 79 due to the ongoing effort to establish market acceptance and position for its health prevention solutions (previous year [ … ]
Fri, 30.04.2021
IGEA Pharma N.V.
IGEA to get SIX approval to delay the 2020 annual report disclosure
Hoofddorp, the Netherlands, 30 April 2021. IGEA Pharma N.V. (SIX: IGPH) today announced the grant of a temporary exemption from its disclosure obligations with respect to the 2020 annual report.
As anticipated on 28 April 2021, certain decisions taken by the last extraordinary ge [ … ]
Wed, 28.04.2021
IGEA Pharma N.V.
IGEA announces extraordinary general meeting results
Hoofddorp, the Netherlands, 28 April 2021. IGEA Pharma N.V. (SIX: IGPH) today announced that the extraordinary general meeting unanimously approved all the Board of directors' proposals. The minutes of the meeting is available at https://www.igeapharma.nl/category/information-for-shareholders/
[ … ]
Thu, 15.04.2021
IGEA Pharma N.V.
IGEA to secure convertible bond commitment with Negma Group
Hoofddorp, the Netherlands, 15 April 2021. IGEA Pharma N.V. (SIX: IGPH) today announced the signing of a two-year convertible bond commitment with UAE-based Negma Group.
The deal will make available up to EUR 2 million, already extendable up to EUR 10 million once the business with Blue [ … ]
Wed, 14.04.2021
IGEA Pharma N.V.
IGEA and its CFO end collaboration
Hoofddorp, the Netherlands, 14 April 2021. IGEA Pharma N.V. (SIX: IGPH) today announced that the collaboration with Patrick Pozzorini is terminated. The formed CFO resigned due to personal reasons.
According to the ongoing business combination with Blue Sky Natural Resources LTD, on which the extraordinary gener [ … ]
Sun, 06.12.2020
IGEA Pharma N.V.
IGEA ensures 'Alz1' supply for the EU market
Hoofddorp, the Netherlands, 6 December 2020. IGEA Pharma N.V. (SIX: IGPH) today announced the signature of an agreement with CSM Europe for the 'CE' compliant supply of Alz1. The distribution of Alz1 on a wholesale basis in selected EU markets is expected to start within the first half of 2021.
***
Ab [ … ]
Wed, 21.10.2020
IGEA Pharma N.V.
IGEA announces changes in its board
Hoofddorp, the Netherlands, 21 October 2020. IGEA Pharma N.V. (SIX: IGPH) today announced the resignation of Mr. Mark De Simone from the board of directors for professional reasons related to other executive activities.
***
About IGEA
IGEA Pharma N.V. focuses on health-tech and med-tech products and devices. H [ … ]
Wed, 02.09.2020
IGEA Pharma N.V.
IGEA discloses its half-2020 financials
Hoofddorp, the Netherlands, 2 September 2020. IGEA Pharma N.V. (SIX: IGPH) today announced the disclosure of its half-2020 financials.
Highlights
The Group generated only marginal revenue for the six months ended 30 June 2020 (same as previous period) due to the ongoing market launch of its products. An inc [ … ]